EP3656765

GRÜNENTHAL GMBH
Application Number
EP19214275A
Filing Date
Jul 22, 2011
Status
Granted And Under Opposition
Mar 12, 2021
Grant Date
Apr 14, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3656765B1 was granted on Apr 14, 2021 by Grünenthal Gmbh The patent is currently Granted And Under Opposition.

The table below shows 6 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM&WITTKOPP PATENTANWALTE PARTMBBJan 14, 2022WITHDRAWN
PAJARO LIMITEDJan 14, 2022WITHDRAWN
MSN LABORATORIES PVT LIMITEDJan 13, 2022ADMISSIBLE
INSUD PHARMA SLJan 13, 2022WITHDRAWN
KRAUS & LEDERER PARTGMBBJan 13, 2022WITHDRAWN
G. L. PHARMA GMBHApr 15, 2021WITHDRAWN

The table below shows the patents of Grünenthal Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3995135Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid SaltJul 13, 20222
EP3210965Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolNov 17, 20213
EP3241550(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsJul 22, 20204

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.